Products are for research use only, not for human use

Literature Depth Index

Every compound in the research library placed A to F by how much peer-reviewed literature exists on it and in which model that work was done.

What the Tiers Describe

Each tier describes the published literature on a compound: how much of it there is, how many independent groups produced it, and which model it was done in, from controlled studies in humans to animal models, cell culture and binding assays. A tier is a statement about publications. It says nothing about what any study found, and it is not a recommendation for or against any compound.

Tiers run from A (an extensive controlled literature from many independent groups) to F(little or no literature specific to the compound). The column beside each name is the compound's receptor or structural class, stated in molecular terms, or “Class not stated” where no class can be given without inventing one.

For a compound's structure, sequence and certificates, see its compound hub. The researcher's guide to peptides covers the fundamentals this index is read against.

Distribution Across Tiers

How the 233 compounds in the Volta Peptides research database fall across the six tiers. Most research peptides sit in the C to E range, where the literature is mainly animal and cell-culture work.

Filter & Search

Showing 233 of 233 compoundssorted by literature tier (A first)
AbaloparatideClass not stated
A
AfamelanotideMelanocortin receptor agonist
A
AlbiglutideGLP-1 receptor agonist
A
Angiotensin IIClass not stated
A
BivalirudinClass not stated
A
BremelanotideMelanocortin receptor agonist (MC3R / MC4R)
A
BuserelinPeptide hormone
A
Calcitonin (Salmon)Class not stated
A
Calcitonin SalmonClass not stated
A
CarbetocinPeptide hormone
A
CetrorelixPeptide hormone
A
CGRPClass not stated
A
DegarelixPeptide hormone
A
DesirudinClass not stated
A
DesmopressinPeptide hormone
A
DifelikefalinClass not stated
A
EnfuvirtideClass not stated
A
EptifibatideClass not stated
A
ExenatideGLP-1 receptor agonist
A
GanirelixPeptide hormone
A
GLP-1Class not stated
A
GLP-1 DGGLP-1 receptor agonist
A
GLP-1 LRGLP-1 receptor agonist
A
GLP-1 SMGLP-1 receptor agonist
A
GLP-2 TZGIP and GLP-1 receptor dual agonist
A
GlucagonClass not stated
A
GonadorelinPeptide hormone
A
GoserelinPeptide hormone
A
Growth HormoneClass not stated
A
HCGGlycoprotein hormone
A
HGH 191AARecombinant human growth hormone (191 residues)
A
HistrelinPeptide hormone
A
HMGClass not stated
A
IcatibantClass not stated
A
IGF-1IGF-1 analogue
A
LanreotideClass not stated
A
LeuprolidePeptide hormone
A
LinaclotideClass not stated
A
LixisenatideGLP-1 receptor agonist
A
MacimorelinGrowth hormone secretagogue receptor (GHS-R1a) agonist
A
Melanotan I (Afamelanotide)Melanocortin 1 receptor agonist
A
NafarelinPeptide hormone
A
NesiritideClass not stated
A
OctreotideClass not stated
A
OxytocinPeptide hormone
A
PasireotideClass not stated
A
PlecanatideClass not stated
A
PramlintideAmylin analogue
A
PT-141Melanocortin receptor agonist (MC3R / MC4R)
A
PTH (Parathyroid Hormone)Class not stated
A
RomiplostimClass not stated
A
SetmelanotideClass not stated
A
Somatropin (rHGH)Recombinant human growth hormone (191 residues)
A
SS-31Mitochondrial peptide
A
TeduglutideClass not stated
A
TeriparatideClass not stated
A
TerlipressinPeptide hormone
A
TesamorelinGHRH analogue (GHRH receptor agonist)
A
TriptorelinPeptide hormone
A
VasopressinPeptide hormone
A
ZiconotideClass not stated
A
AmylinClass not stated
B
AnamorelinGrowth hormone secretagogue receptor (GHS-R1a) agonist
B
Atrial Natriuretic PeptideClass not stated
B
B-type Natriuretic PeptideClass not stated
B
BradykininClass not stated
B
CagrilintideAmylin analogue
B
Cholecystokinin (CCK)Class not stated
B
DanuglipronClass not stated
B
EnclomipheneSelective estrogen receptor modulator (non-peptide)
B
Endothelin-1Class not stated
B
GhrelinGrowth hormone secretagogue receptor (GHS-R1a) agonist
B
GLP-3 RTGLP-1, GIP and glucagon receptor triple agonist
B
GlutathioneThiol tripeptide
B
Kisspeptin-10KISS1 receptor agonist
B
L-CarnitineClass not stated
B
LarazotideClass not stated
B
Neuropeptide YNeuropeptide
B
OrforglipronClass not stated
B
Peptide YY (PYY)Class not stated
B
SomatostatinClass not stated
B
Substance PNeuropeptide
B
SurvodutideGlucagon and GLP-1 receptor dual agonist
B
Thymosin Beta-4Class not stated
B
TRH (Thyrotropin-Releasing Hormone)Class not stated
B
VIP (Vasoactive Intestinal Peptide)Neuropeptide
B
ACE-031Activin receptor IIB Fc fusion (ligand trap)
C
AICARClass not stated
C
AmycretinClass not stated
C
AOD-9604Class not stated
C
ARA-290 (Cibinetide)Erythropoietin-derived peptide
C
BPC-157Class not stated
C
BrilacidinCathelicidin antimicrobial peptide
C
CerebrolysinClass not stated
C
CJC-1295 with DACGHRH analogue (GHRH receptor agonist)
C
CotadutideGLP-1 and glucagon receptor dual agonist
C
DemoxytocinClass not stated
C
EloralintideAmylin receptor agonist
C
FollistatinClass not stated
C
GHKClass not stated
C
GHK (Glycyl-Histidyl-Lysine)Class not stated
C
GHRP-2Growth hormone secretagogue receptor (GHS-R1a) agonist
C
HexarelinGrowth hormone secretagogue receptor (GHS-R1a) agonist
C
Human Relaxin-2Class not stated
C
KisspeptinPeptide hormone
C
MazdutideGLP-1 and glucagon receptor dual agonist
C
N-Acetyl Selank AmidateClass not stated
C
NAD+ (Nicotinamide Adenine Dinucleotide)Bioregulator / cofactor
C
NoopeptClass not stated
C
Oligopeptide-1 / EGFClass not stated
C
OmigananCathelicidin antimicrobial peptide
C
PemvidutideGLP-1 and glucagon receptor dual agonist
C
PexigananCathelicidin antimicrobial peptide
C
ProstatilenClass not stated
C
RetinalaminClass not stated
C
SermorelinGHRH analogue (GHRH receptor agonist)
C
TabimorelinGrowth hormone secretagogue receptor (GHS-R1a) agonist
C
TesofensineClass not stated
C
ThymalinBioregulator (thymic)
C
Thymosin Alpha-1Class not stated
C
ThymulinClass not stated
C
TrevogrumabClass not stated
C
5-Amino-1MQClass not stated
D
9-Me-BCClass not stated
D
Acetyl Tetrapeptide-3Class not stated
D
AdamaxACTH fragment analogue
D
AdipotideProhibitin-targeting peptide
D
AdrenomedullinClass not stated
D
AHK (Ala-His-Lys)Copper-binding tripeptide
D
AHK-Cu (Copper AHK)Copper-binding tripeptide
D
AlexamorelinGrowth hormone secretagogue receptor (GHS-R1a) agonist
D
Alpha-DefensinsCathelicidin antimicrobial peptide
D
Angiotensin 1-7Class not stated
D
ApelinClass not stated
D
Astressin-BClass not stated
D
B7-33Class not stated
D
BAM-15Class not stated
D
Beta-DefensinsCathelicidin antimicrobial peptide
D
BPC-157 + TB-500Class not stated
D
BronchogenClass not stated
D
CAGRILINTIDE + GLP-1 SMAmylin receptor agonist
D
CardiogenBioregulator
D
CartalaxClass not stated
D
ChonlutenClass not stated
D
CJC-1295GHRH analogue (GHRH receptor agonist)
D
CortagenClass not stated
D
CortexinClass not stated
D
Decapeptide-12Class not stated
D
DermorphinClass not stated
D
DSIPNeuropeptide
D
EpithalonBioregulator / cofactor
D
FGL(S)Class not stated
D
Follistatin 344IGF-1 analogue
D
Follistatin-315Activin receptor IIB Fc fusion (ligand trap)
D
FOXO4-DRIClass not stated
D
FOXO4-DRIClass not stated
D
GDF-11Class not stated
D
GHRP-6Growth hormone secretagogue receptor (GHS-R1a) agonist
D
HGH Fragment 176-191Growth hormone fragment
D
Histatin-5Cathelicidin antimicrobial peptide
D
HumaninMitochondrial peptide
D
IGF-1 DESIGF-1 analogue
D
IGF-1 LR3IGF-1 analogue
D
IM862Class not stated
D
IpamorelinGrowth hormone secretagogue receptor (GHS-R1a) agonist
D
KPVClass not stated
D
LactoferricinCathelicidin antimicrobial peptide
D
LivagenClass not stated
D
LL-37Cathelicidin antimicrobial peptide
D
Melanostatin-DM (Nonapeptide-2)Class not stated
D
MelittinCathelicidin antimicrobial peptide
D
MGFIGF-1 analogue
D
MOTS-cMitochondrial peptide
D
Myostatin PropeptideClass not stated
D
N-Acetyl Epithalon AmidateClass not stated
D
N-Acetyl Semax AmidateClass not stated
D
Neuromedin UClass not stated
D
NeuroxelinClass not stated
D
Nonapeptide-1Class not stated
D
OS-01 (OneSkin Peptide)Class not stated
D
OvagenClass not stated
D
P21Class not stated
D
PACAPNeuropeptide
D
Pal-AHKClass not stated
D
Pal-GHK (Palmitoyl Tripeptide-1)Class not stated
D
Palmitoyl Dipeptide-6Class not stated
D
PancragenClass not stated
D
PE-22-28Class not stated
D
PEG-MGFIGF-1 splice-variant peptide
D
Pentapeptide-18 (Leuphasyl)Class not stated
D
PGPIPNClass not stated
D
PinealonClass not stated
D
PNC-27Class not stated
D
ProstamaxClass not stated
D
PTD-DBMClass not stated
D
Rigin (Palmitoyl Tetrapeptide-7)Class not stated
D
SelankClass not stated
D
SemaxClass not stated
D
SLU-PP-332Estrogen-related receptor agonist
D
SYN-AKEClass not stated
D
SYN-COLL (Palmitoyl Tripeptide-5)Class not stated
D
Tat-Beclin 1Class not stated
D
TB-500Class not stated
D
TB-500 Fragment 17-23Class not stated
D
TestagenClass not stated
D
ThymagenClass not stated
D
ThymogenClass not stated
D
UroguanylinClass not stated
D
VesiluteBioregulator
D
VesugenBioregulator
D
Vialox (Pentapeptide-3)Class not stated
D
VilonBioregulator (thymic)
D
Acetyl Tetrapeptide-5Class not stated
F
ArgirelineClass not stated
F
Biotinoyl Tripeptide-1Class not stated
F
CerlutenClass not stated
F
Collagen PeptidesClass not stated
F
Copper Tripeptide-1Class not stated
F
DihexaClass not stated
F
DS-5Class not stated
F
GHK-CuCopper-binding tripeptide
F
KristagenClass not stated
F
MatrixylClass not stated
F
Matrixyl 3000Class not stated
F
Melanotan IIMelanocortin receptor agonist
F
Myristoyl Pentapeptide-17Class not stated
F
Palmitoyl Tetrapeptide-7Class not stated
F
Palmitoyl Tripeptide-1Class not stated
F
Palmitoyl Tripeptide-5Class not stated
F
Sh-Polypeptide-1Class not stated
F
Snap-8Class not stated
F
Tripeptide-29Class not stated
F
ZhenolutenClass not stated
F

Tier Definitions

A

Tier A: Extensive controlled human literature

Many randomised, controlled studies in humans, published by independent groups, alongside a large preclinical and analytical literature. The tier describes how much has been published and how, not what any study found.

B

Tier B: Controlled human studies

Randomised, controlled studies in humans have been published, from fewer groups or over a narrower range of designs than tier A, with a supporting preclinical literature.

C

Tier C: Small or early human studies

Published human data is limited to small, early or uncontrolled studies. Most of the literature is animal and cell-culture work.

D

Tier D: Animal models

The literature is mainly in vivo animal work, reproduced in more than one laboratory, with supporting cell-culture data. No controlled human study has been published.

E

Tier E: Cell culture and in vitro

The literature is mainly cell culture, receptor-binding assays or computational modelling, often from a single laboratory.

F

Tier F: Little or no compound-specific literature

Few or no peer-reviewed publications address this compound directly. What exists is basic characterisation or analogy to a related structure.

How a Tier Is Assigned

Four properties of the literature decide a tier: (1) volume, the number of peer-reviewed publications on the compound itself rather than on a related molecule; (2) model, whether the work was done in controlled human studies, in animal models, or in cell culture and binding assays; (3) design, whether studies were randomised and controlled; and (4) replication, whether independent laboratories produced the same kind of data.

The model carries the most weight, because it is the one property a reader cannot infer from a citation count. A compound with a large animal literature and no controlled human study is placed in tier D however many papers it has.

Assignments are checked against PubMed and ClinicalTrials.gov and moved when the literature moves. A compound's hub lists its structure and the certificates for its batches.

Reading the Index

The literature on research peptides is very uneven. A few receptor agonists, the GLP-1 receptor agonists among them, have very large published literatures produced by long industrial programmes, while many short research peptides have a handful of papers from one or two laboratories.

Publication bias applies throughout: a study that found something is more likely to be published than one that did not, so a large literature is not the same thing as a settled one. A tier records the shape of what has been published and should be read alongside the primary papers.

The glossary defines the analytical terms used across the library, and the storage and handling guide covers stability in solution.

Frequently Asked Questions

What does a low tier mean?

That little has been published on the compound, or that what has been published was done in cell culture or animal models. It is a statement about the literature, not about the compound.

How often are tiers updated?

The index is reviewed quarterly against new publications on PubMed and new study registrations on ClinicalTrials.gov, and a tier moves when the shape of the literature does.

Why is the class column blank for some compounds?

The column states a receptor or structural class. Some compounds have no characterised receptor, and the index prints “Class not stated” rather than naming them by what they were studied for.

Research Disclaimer

All information presented on this page is for educational and informational purposes only, intended for in vitro research use by qualified researchers. Literature tiers reflect the current state of published scientific literature and are not medical advice. Not for human consumption. Volta Peptides does not make claims regarding the therapeutic efficacy of any compound for human use. Researchers should consult primary literature sources and applicable regulatory guidelines before making any research decisions. All peptides are sold strictly as research chemicals and are not intended for human or veterinary use.

Explore More Resources

The catalogue, the certificate archive and the researcher's guide.

Your Cart

Your cart is empty

Browse our catalog to add research compounds.